Anatomy & Body Systems
1. The Joint
A typical synovial joint consists of:
- Articular cartilage (smooth covering)
- Synovial membrane (produces lubricating fluid)
- Joint capsule (fibrous enclosure)
- Synovial fluid (nutrients and lubrication)
- Ligaments (stability)
2. Immune System
In juvenile arthritis:
- T-cells become dysregulated
- Autoantibodies may be produced
- Inflammatory cytokines are released
- Chronic inflammation results
3. Growing Bodies
Children's bodies are affected differently:
- Growth plates may be damaged
- Growth can be asymmetrical
- Physical development may be delayed
- Eyes: Uveitis (inner eye inflammation)
- Skin: Rashes
- Internal organs: Heart, lungs, liver, spleen (in systemic JIA)
- Growth: May be impaired
Types & Classifications
International League of Associations for Rheumatology (ILAR) Classification
| Type | Features |
|---|---|
| Oligoarticular JIA | ≤ 4 joints involved, most common |
| Polyarticular JIA (RF+) | ≥ 5 joints, rheumatoid factor positive |
| Polyarticular JIA (RF-) | ≥ 5 joints, rheumatoid factor negative |
| Systemic JIA | Fever, rash, internal organ involvement |
| Enthesitis-related JIA | Arthritis with enthesitis |
| Psoriatic Arthritis | Arthritis with psoriasis |
| Undifferentiated JIA | Does not fit other categories |
Causes & Root Factors
1. Autoimmune Dysfunction
The exact cause is unknown, but JA is considered an autoimmune disorder:
- The immune system attacks healthy joint tissues
- T-cells and inflammatory cytokines mediate damage
- Genetic predisposition exists
2. Genetic Factors
- Family history increases risk
- Specific HLA genes associated
- Not directly inherited
- Environmental triggers
- Infections (possibly)
- Stress
- Hormonal factors
Risk Factors
- Age (peaks 1-3 years and 8-12 years)
- Female sex (for most types)
- Family history
- Specific genetic markers
- None clearly established
- Early treatment improves outcomes
Signs & Characteristics
Joint Symptoms:
- Joint swelling
- Joint pain (may be subtle)
- Stiffness (worse in morning)
- Warmth over joints
- Reduced range of motion
Systemic Symptoms (Systemic JIA):
- High fever
- Rash
- Fatigue
- Organ involvement
- Often affects knees, ankles, wrists
- May be asymmetric
- Morning stiffness typical
- Improvement with activity
Clinical Assessment
Key Questions:
- When did symptoms start? How quickly did they develop?
- Which joints are affected? Is it one or many?
- Stiffness: Worse in morning? Improves with activity?
- Pain: How much does it bother the child?
- Function: Any difficulty with activities?
- Other symptoms: Fever, rash, eye problems?
- Family history: Autoimmune conditions?
Observation:
- Swelling
- Gait abnormalities
- Posture changes
Joint Assessment:
- Swelling and warmth
- Range of motion
- Tenderness
- Muscle strength
Diagnostics
Blood Tests:
- Rheumatoid factor (RF)
- Anti-CCP antibodies
- ANA (antinuclear antibodies)
- ESR (inflammation marker)
- CRP (inflammation marker)
- CBC (complete blood count)
X-Ray:
- Assesses joint damage
- Growth plate evaluation
Ultrasound/MRI:
- Early detection of synovitis
- Assessment of soft tissues
- Regular screening for uveitis
- Slit-lamp examination
Differential Diagnosis
| Condition | Key Features |
|---|---|
| Growing pains | Bilateral, no swelling, activity-related |
| Infection | Acute onset, fever, elevated WBC |
| Lyme disease | Tick exposure, targetoid rash |
| Leukemia | Fatigue, bruising, abnormal CBC |
| Hypermobility | Flexible joints, no inflammation |
Red Flags
- Fever
- Weight loss
- Significant pain
- Morning stiffness > 30 minutes
Conventional Treatments
1. NSAIDs:
- Ibuprofen, naproxen
- Reduce pain and inflammation
2. Disease-Modifying Antirheumatic Drugs (DMARDs):
- Methotrexate (most common)
- Sulfasalazine
3. Biologic Agents:
- TNF inhibitors (etanercept, adalimumab)
- IL-6 inhibitors (tocilizumab)
- T-cell co-stimulation blockers (abatacept)
- Physical therapy
- Occupational therapy
- Regular eye exams
- Growth monitoring
Integrative Treatments
Approach:
- Constitutional treatment
- Individualized prescribing
- Focus on overall health
- Safe for children
Remedies Considered:
- Pulsatilla
- Calcaria carbonica
- Phosphorus
- Others based on constitution
Approach:
- Vata-pacifying treatments
- Ama-pachana (toxin elimination)
- Joint-strengthening approaches
- Dietary modifications for children
Goals:
- Maintain joint mobility
- Prevent muscle atrophy
- Improve function
- Pain management
Supportive:
- Vitamin D
- B vitamins
- Anti-inflammatory nutrients
Self Care
- Regular exercise as tolerated
- Joint protection techniques
- Good posture
- Adequate rest
- Balanced diet
- Understanding the condition
- Encouraging independence
- School accommodations
- Emotional support
Prevention
Screening
- Regular eye exams (critical)
- Growth monitoring
- Joint assessment
- Prompt evaluation of symptoms
- Early treatment
- Regular follow-up
When to Seek Help
Prompt Evaluation If:
- Joint swelling lasting > 6 weeks
- Morning stiffness > 30 minutes
- Limping
- Unexplained rash with fever
- Eye pain or redness
Prognosis
Expected Outcomes
- Many achieve remission with treatment
- Some have persistent disease into adulthood
- Early treatment improves outcomes
- Most children lead full lives
Factors Affecting Outcome
- Type of JIA
- Response to treatment
- Early diagnosis
- Family support
FAQ
They are related but different. Some subtypes of JIA resemble adult rheumatoid arthritis, while others are unique to children. The course and treatment can differ.
Some children experience remission and may not need ongoing treatment, while others have active disease into adulthood. The outcome varies significantly between individuals.
Most children with JA can participate in activities with appropriate modifications. Swimming and other low-impact exercises are often well-tolerated. Activity should be guided by symptoms.
Children with JIA should have slit-lamp eye exams every 3-12 months, depending on their risk factors and disease activity.
Last Updated: March 2026 Content Author: Healers Clinic Medical Team Medical Disclaimer: This content is for educational purposes only.